These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22294127)

  • 21. Behavioral measures of neurotoxicity.
    Cory-Slechta DA
    Neurotoxicology; 1989; 10(2):271-95. PubMed ID: 2616068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofunctional test batteries in safety pharmacology - Current and emerging considerations for the drug development process.
    Jackson SJ; Authier S; Brohmann H; Goody SMG; Jones D; Prior H; Rosch A; Traebert M; Tse K; Valentin JP; Milne A
    J Pharmacol Toxicol Methods; 2019; 100():106602. PubMed ID: 31238094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral and antiepileptic effects of acute administration of the extract of the plant Cestrum nocturnum Lin (lady of the night).
    Pérez-Saad H; Buznego MT
    Epilepsy Behav; 2008 Apr; 12(3):366-72. PubMed ID: 18276193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurobehavioral toxicity with low doses of sarin and soman.
    Sirkka U; Nieminen SA; Ylitalo P
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):245-50. PubMed ID: 2374471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategy for the assessment of neurobehavioral consequences of environmental factors.
    Tilson HA; Cabe PA
    Environ Health Perspect; 1978 Oct; 26():287-99. PubMed ID: 720319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are there any remarkable effects of prenatal exposure to food colourings on neurobehaviour and learning process in rat offspring?
    Doguc DK; Aylak F; Ilhan I; Kulac E; Gultekin F
    Nutr Neurosci; 2015 Jan; 18(1):12-21. PubMed ID: 24257113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotoxicity of misonidazole in rats following intravenous administration.
    Graziano MJ; Henck JW; Meierhenry EF; Gough AW
    Pharmacol Res; 1996 Jun; 33(6):307-18. PubMed ID: 8971952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist.
    Kłodzińska A; Tatarczyńska E; Stachowicz K; Chojnacka-Wójcik E
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):113-26. PubMed ID: 15082872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orthostatic hypotension induced by postural change in the rat (tilt test).
    Guillaume P; Hervé S; Picard S; Lacroix P
    Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.45. PubMed ID: 22294225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional observational battery and motor activity in rats after single administration of two NHE 1 inhibitors.
    Hübler N; Gottschling B; Jacobs M; von Landenberg F; Hewicker-Trautwein M
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):266-76. PubMed ID: 16239169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the non-invasive faecal pellet assessment method as an early drug discovery screen for gastrointestinal liability.
    Marks L; Beard E; Cobey D; Moore N; Motyer V; Valentin JP; Ewart L
    J Pharmacol Toxicol Methods; 2013; 68(1):123-36. PubMed ID: 23542059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vigilance-controlled quantified EEG in safety pharmacology.
    Dürmüller N; Porsolt RD; Scherschlicht R
    Curr Protoc Pharmacol; 2001 May; Chapter 10():Unit 10.6. PubMed ID: 22293963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of neurotoxicity potential in rats: the functional observational battery.
    Boucard A; Bétat AM; Forster R; Simonnard A; Froget G
    Curr Protoc Pharmacol; 2010 Dec; Chapter 10():Unit 10.12. PubMed ID: 21935896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of the reserpine test in psychopharmacology.
    Bourin M; Poncelet M; Chermat R; Simon P
    Arzneimittelforschung; 1983; 33(8):1173-6. PubMed ID: 6685496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of non-clinical behavioral CNS safety assessment: An intercompany comparison.
    Himmel HM; ; Delaunois A; Deurinck M; Dinklo T; Eriksson Faelker TM; Habermann C; Heers C; Hempel K; Lorenz H; Rosch A; Schauerte H; Teuns G; Traebert M; van Amsterdam C; van der Linde H
    J Pharmacol Toxicol Methods; 2019; 99():106571. PubMed ID: 30928509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting functional neurotoxicity in the course of safety evaluations with laboratory animals.
    Schaeppi U
    Toxicology; 1988 May; 49(2-3):409-16. PubMed ID: 3287697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuating effects of testosterone on depressive-like behavior in the forced swim test in healthy male rats.
    Buddenberg TE; Komorowski M; Ruocco LA; Silva MA; Topic B
    Brain Res Bull; 2009 May; 79(3-4):182-6. PubMed ID: 19429189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An optimised methodology for the neurobehavioural assessment in rodents.
    Moscardo E; Maurin A; Dorigatti R; Champeroux P; Richard S
    J Pharmacol Toxicol Methods; 2007; 56(2):239-55. PubMed ID: 17629504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures.
    Gasior M; Ungard JT; Witkin JM
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1148-56. PubMed ID: 10454489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.